Patent · US Active

Synthetic agonists of TLR9

US7960362B2 · kind B2 · utility

14Cited by

3References

6Claims

0Family size

Assignee

IDERA PHARMACEUTICALS, INC. · US

Inventors

Ekambar Kandimalla · Upton, US
Mallikarjuna Reddy Putta · Lexington, US
Daqing Wang · Bedford, US
Dong Yu · Lowell, US
Lakshmi Bhagat · Framingham, US
Sudhir Agrawal · Shrewsbury, US

Key dates

Filing date	Jul 31, 2008
Grant date	Jun 14, 2011
Priority date	—
Expiry date	Jul 31, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to synthetic chemical compositions that are useful for modulation of Toll-Like Receptor (TLR)-mediated immune responses. In particular, the invention relates to agonists of Toll-Like Receptor 9 (TLR9) that generate unique cytokine and chemokine profiles.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.